A Four Gene-Based Risk Score System Associated with Chemoradiotherapy Response and Tumor Recurrence in Rectal Cancer by Co-Expression Network Analysis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–582. doi:10.1016/S1470-2045(11)70097-321596621
   PubMed Web of Science ®Google Scholar
• Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized Phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;39(16):1926–1933. doi:10.1200/JCO.2011.40.1836
   Web of Science ®Google Scholar
• Bosset J, Calais G, Mineur L, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol. 2014;15(2):184–190. doi:10.1016/S1470-2045(13)70599-024440473
   PubMed Web of Science ®Google Scholar
• Creavin B, Ryan E, Martin S, et al. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Br J Cancer. 2017;116(2):169–174. doi:10.1038/bjc.2016.41727997526
   PubMed Web of Science ®Google Scholar
• Ha Y, Tak K, Kim C, et al. PSMB8 as a candidate marker of responsiveness to preoperative radiation therapy in rectal cancer patients. Int J Radiat Oncol Biol Phys. 2017;98(5):1164–1173. doi:10.1016/j.ijrobp.2017.03.02328721901
   PubMed Web of Science ®Google Scholar
• Chow O, Kuk D, Keskin M, et al. KRAS and Combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy. Ann Surg Oncol. 2016;23(8):2548–2555. doi:10.1245/s10434-016-5205-427020587
   PubMed Web of Science ®Google Scholar
• Gollins S, West N, Sebag-Montefiore D, et al. Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. Br J Cancer. 2017;117(9):1286–1294. doi:10.1038/bjc.2017.29428859058
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559. doi:10.1186/1471-2105-9-55919114008
   PubMed Web of Science ®Google Scholar
• Horvath S, Dong J. Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol. 2008;4(8):e1000117. doi:10.1371/journal.pcbi.100011718704157
   PubMed Web of Science ®Google Scholar
• Giulietti M, Occhipinti G, Principato G, Piva F. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cell Oncol (Dordr). 2016;39(4):379–388. doi:10.1007/s13402-016-0283-727240826
   PubMed Web of Science ®Google Scholar
• Chen P, Wang F, Feng J, et al. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma. Oncotarget. 2017;8(30):48948–48958. doi:10.18632/oncotarget.1689628430663
   PubMedGoogle Scholar
• Magani F, Bray E, Martinez M, et al. Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer. Mol Syst Biol. 2018;14(8):e8202. doi:10.15252/msb.2018820230108134
   PubMed Web of Science ®Google Scholar
• Wang X, Ghareeb WM, Lu X, Huang Y, Huang S, Chi P. Coexpression network analysis linked H2AFJ to chemoradiation resistance in colorectal cancer. J Cell Biochem. 2019;120(6):10351–10362. doi:10.1002/jcb.2831930565747
   PubMed Web of Science ®Google Scholar
• Gonçalves-Ribeiro S, Sanz-Pamplona R, Vidal A, et al. Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling. Ann Oncol. 2017;28(9):2160–2168. doi:10.1093/annonc/mdx29328911071
   PubMed Web of Science ®Google Scholar
• Yip A, Horvath S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics. 2007;8(1):22. doi:10.1186/1471-2105-8-2217250769
   PubMedGoogle Scholar
• Botía J, Vandrovcova J, Forabosco P, et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol. 2017;11(1):47. doi:10.1186/s12918-017-0420-628403906
   PubMedGoogle Scholar
• Huang Da W, Sherman B, Lempicki R. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.21119131956
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39:D561–D568. doi:10.1093/nar/gkq97321045058
   PubMed Web of Science ®Google Scholar
• Su G, Morris J, Demchak B, Bader G. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014;47(1):8–13. doi:10.1002/0471250953.bi0813s4725199793
   PubMedGoogle Scholar
• Lee IH, Kang K, Kang BW, et al. Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Med Oncol. 2018;35(11):145. doi:10.1007/s12032-018-1202-830206710
   PubMed Web of Science ®Google Scholar
• Cho E, Park IJ, Yeom SS, et al. A multigene model for predicting tumor responsiveness after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2019;105(4):834–842. doi:10.1016/j.ijrobp.2019.07.05831419511
   PubMed Web of Science ®Google Scholar
• Sun M, Sun T, He Z, Xiong B. Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis. Oncotarget. 2017;8(41):69594–69609. doi:10.18632/oncotarget.1864629050227
   PubMedGoogle Scholar
• Koyama F, Lopes Ramos C, Ledesma F, et al. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer. Br J Surg. 2018;105(2):e192–e203. doi:10.1002/bjs.1069529341150
   PubMed Web of Science ®Google Scholar
• Dycka F, Bobal P, Mazanec K, Bobalova J. Rapid and efficient protein enzymatic digestion: an experimental comparison. Electrophoresis. 2012;33(2):288–295. doi:10.1002/elps.20110012322170586
   PubMed Web of Science ®Google Scholar
• Gómez Del Pulgar T, Cebrián A, Fernández-Aceñero M, et al. Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer. J Cell Mol Med. 2016;20(9):1729–1736. doi:10.1111/jcmm.1287927171907
   PubMed Web of Science ®Google Scholar
• Forrester HB, Li J, Leong T, Mckay MJ, Sprung CN. Identification of a radiation sensitivity gene expression profile in primary fibroblasts derived from patients who developed radiotherapy-induced fibrosis. Radiother Oncol. 2014;111(2):186–193. doi:10.1016/j.radonc.2014.03.00724835153
   PubMed Web of Science ®Google Scholar
• Kurtul N, Tasdemir EA, Unal D, Izmirli M, Eroglu C. SPARC: as a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy. Cancer Biomark. 2017;18(4):459–466. doi:10.3233/CBM-16173328009327
   PubMed Web of Science ®Google Scholar
• Zhang W, Ge Y, Cheng Q, Zhang Q, Fang L, Zheng J. Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment. Oncotarget. 2018;9(4):5480–5491. doi:10.18632/oncotarget.2386929435195
   PubMedGoogle Scholar
• Henke A, Grace OC, Ashley GR, et al. Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer. PLoS One. 2012;7(8):e42516. doi:10.1371/journal.pone.004251622880013
   PubMed Web of Science ®Google Scholar
• S J L, Chen DL, Zhang WB, Shen C, Che GW. Prognostic value of stromal decorin expression in patients with breast cancer: a meta-analysis. J Thorac Dis. 2015;7(11):1939–1950. doi:10.3978/j.issn.2072-1439.2015.11.2926716032
   PubMed Web of Science ®Google Scholar
• Zlajpah M, Hauptman N, Bostjancic E, Zidar N. Differential expression of extracellular matrixrelated genes DCN, EPHA4, FN1, SPARC, SPON2 and SPP1 in colorectal carcinogenesis. Oncol Rep. 2019;42:1539–1548.
   PubMed Web of Science ®Google Scholar
• Nam JM, Chung Y, Hsu HC, Park CC. beta1 integrin targeting to enhance radiation therapy. Int J Radiat Biol. 2009;85(11):923–928. doi:10.3109/0955300090323287619895268
   PubMed Web of Science ®Google Scholar
• Lopes-Ramos C, Koyama FC, Habr-Gama A, et al. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer. Cancer Genet. 2015;208(6):319–326. doi:10.1016/j.cancergen.2015.03.01025963525
   PubMed Web of Science ®Google Scholar
• Guo Y, Jiang W, Ao L, et al. A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers. Radiother Oncol. 2018;129(1):149–153. doi:10.1016/j.radonc.2018.01.01029402470
   PubMed Web of Science ®Google Scholar
• Campayo M, Navarro A, Benitez JC, et al. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer. PLoS One. 2018;13(11):e206542. doi:10.1371/journal.pone.0206542
   PubMed Web of Science ®Google Scholar